Stocks Near Their 52-Week High — Performance View · Pharmaceutical Preparations
42 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — at or below it, not necessarily at a new one — largest first. Performance columns. Filtered to Pharmaceutical Preparations. Data as of close · Checked
Filters2
1–42 of 42
| LLY | Lilly (Eli) | +9.98% | +22.35% | +19.07% | +44.02% | +58.30% | +31.89% | 3.6% | 3.1% | 1.79 | 107K | 1418.07 | +0.62% | 192K |
| JNJ | Johnson & Johnson | +1.88% | +8.49% | +7.45% | +23.05% | +48.37% | +33.49% | 2.5% | 2.4% | 1.35 | 276K | 276.34 | +3.82% | 373K |
| ONC | Beone Medicines Ltd. | +1.07% | +4.05% | +14.39% | +20.70% | +21.09% | +24.24% | 2.6% | 2.6% | 1.30 | 31K | 377.48 | +6.36% | 40K |
| ABBV | AbbVie | +2.97% | +10.55% | +20.92% | +43.89% | +39.10% | +29.07% | 2.6% | 2.4% | 1.70 | 201K | 294.91 | +3.16% | 341K |
| MRK | Merck | +6.58% | +5.94% | +17.16% | +32.43% | +82.26% | +42.82% | 2.7% | 2.9% | 0.85 | 423K | 150.37 | +3.93% | 358K |
| PFE | Pfizer | +4.44% | +12.05% | +18.33% | +16.19% | +24.71% | +23.65% | 2.5% | 1.9% | 1.64 | 1.9M | 30.79 | +2.70% | 3.2M |
| VRTX | Vertex Pharmaceuticals | +3.63% | +9.30% | +13.38% | +28.42% | +35.24% | +21.08% | 3.8% | 2.9% | 1.30 | 63K | 549.07 | +3.37% | 82K |
| BMY | Bristol Myers Squibb | +5.92% | +7.75% | +0.06% | +13.53% | +39.50% | +19.00% | 2.5% | 2.8% | 0.73 | 662K | 64.20 | +4.04% | 482K |
| REGN | Regeneron Pharmaceuticals | +14.42% | +26.01% | +20.59% | +29.10% | +44.86% | +20.60% | 5.1% | 3.0% | 1.74 | 37K | 930.90 | -4.41% | 65K |
| TEVA | Teva Pharmaceutical Industries Ltd | +4.55% | +6.91% | +20.08% | +15.06% | +103.70% | +33.93% | 3.6% | 2.7% | 1.44 | 400K | 41.80 | -0.24% | 577K |
| RPRX | Royalty Pharma Plc | +4.21% | +19.72% | +18.05% | +33.31% | +81.10% | +74.84% | 2.1% | 2.3% | 0.97 | 208K | 67.56 | +1.82% | 202K |
| UTHR | United Therapeutics Corp | +3.61% | +12.11% | +14.03% | +1.86% | +38.55% | +24.74% | 2.5% | 2.8% | 1.68 | 40K | 607.43 | +0.95% | 68K |
| VTRS | Viatris | +2.53% | +9.63% | +18.29% | +20.58% | +82.59% | +54.45% | 2.2% | 2.4% | 1.11 | 569K | 19.25 | +1.61% | 631K |
| ELAN | Elanco Animal Health Inc | +11.67% | +12.54% | +4.61% | -3.21% | +10.67% | +11.84% | 2.8% | 3.7% | 1.88 | 489K | 25.31 | +2.97% | 920K |
| TGTX | Tg Therapeutics, Inc. | +7.48% | +18.22% | +24.48% | +46.94% | +83.24% | +106.70% | 4.4% | 4.3% | 0.89 | 85K | 61.68 | +1.49% | 76K |
| SYRE | Spyre Therapeutics, Inc. | -0.54% | +23.76% | -3.99% | +35.96% | +318.10% | +202.79% | 4.1% | 5.0% | 1.37 | 79K | 99.19 | -0.14% | 108K |
| KNSA | Kiniksa Pharmaceuticals International, Plc | +0.95% | +24.59% | +25.61% | +65.04% | +156.38% | +132.78% | 4.8% | 5.3% | 1.06 | 42K | 96.08 | +3.15% | 44K |
| AMRX | Amneal Pharmaceuticals, Inc. | -5.58% | -1.60% | +10.45% | +46.62% | +78.30% | +58.55% | 4.8% | 3.9% | 1.58 | 150K | 19.97 | -1.29% | 237K |
| LGND | Ligand Pharmaceuticals Inc | -1.15% | +6.30% | +5.08% | +35.99% | +65.48% | +67.29% | 3.6% | 3.8% | 0.64 | 15K | 316.17 | +0.69% | 9K |
| ARQT | Arcutis Biotherapeutics, Inc. | +8.87% | +41.56% | +29.56% | +42.33% | +38.41% | +17.87% | 4.0% | 5.1% | 1.36 | 143K | 34.23 | +6.90% | 194K |
| OGN | Organon & Co. | +0.65% | +0.80% | +2.36% | +3.59% | +106.87% | +93.44% | 0.2% | 0.3% | 1.04 | 181K | 13.86 | +0.11% | 189K |
| BHC | Bausch Health Companies Inc. | +20.00% | +38.31% | +41.12% | +47.35% | +22.29% | +20.17% | 7.4% | 4.7% | 1.22 | 207K | 8.34 | +2.58% | 253K |
| SLN | Silence Therapeutics Plc | +0.46% | +100.91% | +68.64% | +168.89% | +199.39% | +225.49% | 0.3% | 5.8% | 0.48 | 144K | 19.79 | +0.00% | 70K |
| XNCR | Xencor Inc | +17.16% | +43.68% | +74.98% | +169.46% | +151.83% | +128.80% | 5.9% | 6.3% | 1.38 | 82K | 35.03 | +14.33% | 113K |
| PVLA | Palvella Therapeutics, Inc. | +10.15% | +25.60% | +5.18% | +25.17% | +112.40% | +55.47% | 5.9% | 6.2% | 2.57 | 13K | 162.66 | +6.31% | 34K |
| SEPN | Septerna, Inc. | +8.15% | +34.10% | +21.02% | +93.85% | +138.92% | +71.98% | 4.8% | 5.2% | 2.48 | 23K | 47.88 | +9.47% | 57K |
| ZYME | Zymeworks Inc. | +7.02% | +20.62% | +33.51% | +12.02% | +63.83% | +17.55% | 3.2% | 4.6% | 0.92 | 44K | 30.94 | +2.69% | 40K |
| XERS | Xeris Biopharma Holdings, Inc. | -1.65% | +3.77% | +42.12% | +63.95% | +5.60% | +32.41% | 4.0% | 5.8% | 1.60 | 147K | 10.46 | +0.97% | 234K |
| PCRX | Pacira Biosciences, Inc. | +0.10% | +47.11% | +42.40% | +53.85% | +64.22% | +40.85% | 0.1% | 1.8% | 2.70 | 61K | 36.42 | +0.10% | 165K |
| OPK | OPKO HEALTH, INC. | +10.15% | +22.60% | +35.09% | +58.41% | +28.32% | +43.20% | 3.5% | 4.8% | 0.94 | 233K | 1.79 | +3.47% | 218K |
| AMPH | Amphastar Pharmaceuticals, Inc. | +6.45% | +8.26% | +41.62% | +17.30% | +10.92% | +4.59% | 3.1% | 3.4% | 1.13 | 27K | 28.04 | +3.35% | 31K |
| RIGL | Rigel Pharmaceuticals Inc | +0.90% | +11.36% | +31.05% | +91.88% | +67.32% | +19.87% | 4.3% | 3.5% | 1.23 | 10K | 51.30 | +4.87% | 12K |
| VSTM | Verastem, Inc. | +0.41% | +27.19% | +55.43% | +64.50% | -0.35% | +27.68% | 4.4% | 8.4% | 0.97 | 248K | 9.87 | +0.87% | 240K |
| DMAC | DiaMedica Therapeutics Inc. | +9.77% | +32.64% | +59.38% | +64.98% | +58.21% | +35.72% | 5.9% | 5.4% | 3.01 | 10K | 10.79 | +7.68% | 30K |
| PBYI | PUMA BIOTECHNOLOGY, INC. | +0.75% | +12.62% | +31.57% | +43.76% | +112.50% | +80.00% | 3.4% | 4.0% | 1.60 | 18K | 10.71 | +4.59% | 29K |
| RLYB | Rallybio Corp | -0.81% | -6.44% | -0.62% | +83.39% | +225.71% | +191.42% | 2.3% | 1.3% | 1.84 | 499 | 15.90 | +0.16% | 919 |
| GMAB | Genmab A/S | -3.94% | +45.60% | +84.46% | +97.42% | +91.85% | +78.89% | 3.9% | 4.6% | 0.98 | 334K | 55.08 | -0.74% | 328K |
| RDY | Dr Reddys Laboratories Ltd | +4.31% | +18.25% | +21.97% | +9.73% | +10.06% | +5.20% | 1.4% | 3.3% | 1.01 | 246K | 14.77 | +3.18% | 248K |
| TAK | Takeda Pharmaceutical Co Ltd | +4.54% | +16.32% | +23.66% | +25.99% | +56.97% | +35.21% | 2.0% | 1.5% | 1.33 | 154K | 21.07 | +1.47% | 205K |
| ASND | Ascendis Pharma A/S | +3.28% | +14.03% | +3.25% | +9.35% | +28.36% | +20.94% | 2.2% | 2.4% | 0.89 | 46K | 257.95 | +3.22% | 40K |
| SNY | Sanofi | +12.31% | +19.86% | +10.58% | +8.46% | -5.21% | -2.17% | 2.1% | 1.7% | 2.11 | 211K | 47.44 | +4.65% | 446K |
| NVS | Novartis Ag | +5.74% | +17.22% | +7.05% | +11.28% | +33.18% | +19.65% | 1.6% | 1.6% | 1.00 | 115K | 165.02 | +3.64% | 116K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.